Your browser doesn't support javascript.
loading
Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias.
Sharma, Raahul; Singh, Sameek; Whiting, Zak M; Molitor, Maximilian; Vernall, Andrea J; Grimsey, Natasha L.
Afiliação
  • Sharma R; Department of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand.
  • Singh S; Centre for Brain Research, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand.
  • Whiting ZM; Department of Chemistry, University of Otago, Dunedin 9016, New Zealand.
  • Molitor M; Chemical Biology and Therapeutics Science, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Vernall AJ; Department of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand.
  • Grimsey NL; Centre for Brain Research, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand.
Int J Mol Sci ; 24(7)2023 Mar 29.
Article em En | MEDLINE | ID: mdl-37047385
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Arrestina / Cicloexanóis Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Arrestina / Cicloexanóis Idioma: En Ano de publicação: 2023 Tipo de documento: Article